Dr. Khuddus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4645 NW 8th Ave
Gainesville, FL 32605Phone+1 352-331-8570Fax+1 352-331-9095
Education & Training
- University of FloridaFellowship, Interventional Cardiology, 2007 - 2008
- University of FloridaFellowship, Cardiovascular Disease, 2004 - 2007
- University of FloridaResidency, Internal Medicine, 2001 - 2004
- University of Florida College of MedicineClass of 2001
Certifications & Licensure
- FL State Medical License 2003 - 2026
- TX State Medical License 2012 - 2012
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Intergy EHR, Vitera Healthcare Solutions, LLC, 2013
- CMS Meaningful Use Stage 1 Certification Acumen nEHR, Health IT Services Group, 2012
- Most Compassionate Doctor American Registry
- Join now to see all
Clinical Trials
- Pivotal Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon Start of enrollment: 2013 Jun 18
Publications & Presentations
PubMed
- 287 citationsImproved Outcomes Associated with the use of Shock Protocols: Updates from the National Cardiogenic Shock InitiativeMir B Basir, Navin K. Kapur, Kirit Patel, Murad A Salam, Theodore Schreiber
Catheterization and Cardiovascular Interventions. 2019-06-01 - 148 citationsAn intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung a...Matheen Khuddus, Carl J. Pepine, Eileen M. Handberg, C. Noel Bairey Merz, George Sopko
Journal of Interventional Cardiology. 2010-12-01 - 425 citationsEndovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trialMichel Azizi, Roland E. Schmieder, Felix Mahfoud, Michael A. Weber, Joost Daemen
Lancet. 2018-06-09
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: